Top 50 Most Viewed Posts This Month |
Today This Week Last Week This Month Last Month
|
1. My69z: Sell before putting iP value into the company, (1230) (14) |
2. Rosner: Short Interest Report As of Sat, Aug 3, '13 (1182) |
3. Chasing Stars: Getting started on Investors Hangout. Are you (934) (14) |
4. mightycydy: CYDY's got many "Bites at the apple" remaining -- (896) (17) |
5. Plotinus: Granted I do not have laser insight into the full (851) (28) |
6. ohm20: ohm: how reasonable would it be to assume that (773) (11) |
7. Riztheinvestor: Wonder how many shares are being sold that (754) (3) |
8. BUMPERCARS: Doc isn't planning on giving us anything down (715) (10) |
9. ohm20: It is not a question of if "these guys are not (704) (19) |
10. SamaGong: From ER's Post: "The way I interpret that quote (681) (10) |
11. dfwl28: https://www.nytimes.com/2024/05/08/technology/goo (669) (8) |
12. My69z: Another Dr. Burger Patent: Date of Patent: (669) (6) |
13. MGK_2: this was posted 2/4/2024 (653) (13) |
14. Respert24: Everyone keeps talking about Merck or our BOD (646) (22) |
15. Evil Rabbit: Something to read over the weekend Don’t have (645) (15) |
16. ohm20: I can't help but think the FDA's initial reaction (642) (11) |
17. docj: VANCOUVER, Washington, May 16, 2024 (GLOBE (641) (28) |
18. Katangolo: Thanks, jfl97z. I have a few questions and (641) (14) |
19. Fumbler: If you're using Brave, enable JavaScript and turn (641) (1) |
20. Jake2212: ER: Pembrolizumab is the generic name for (636) (7) |
21. Enjay: An article entitled "Clinical and CSF single-cell (633) (8) |
22. dfwl28: White Paper/ Journal publications. Hopefully. (626) (4) |
23. SamaGong: Great post, Ohm. CCR5 has been studied a lot (622) (7) |
24. Buddyboy20: Many of us (investors) thought highly of Nader. (621) (22) |
25. Albicuz: https://stocktwits.com/Cytomight/message/57180391 (619) (4) |
26. ohm20: It does appear that Leronlimab is available again (617) (15) |
27. Jake2212: ohm: Your comment to Respert that MRK should just (612) (8) |
28. biloxiblues: https://www.trademarkelite.com/trademark/trademar (608) (6) |
29. rodolfo: Well then, I'd be intersted in your opinion why (608) (2) |
30. generactor: I think it's probably the opposite because if an (599) (9) |
31. armyseal: Keep the momo going for Monday .. hit that ask (598) (5) |
32. HHIGambler: There's a snapshot of the proactive video on (592) (4) |
33. HHIGambler: Agree. Let's move on, folks. Not for nothing, but (588) (9) |
34. sean007: Eight months later...We have a Premie...named (587) (7) |
35. sean007: Trademark Elite Serial # (586) (8) |
36. Evil Rabbit: It does appear that Leronlimab is available again (586) (18) |
37. USS JOHNSTON: "Ohmlimab?" (585) (11) |
38. chazzledazzle: Mixed feelings about Nader. I defended him (585) (8) |
39. Katangolo: Why? I’m not interested in beating NP ’s dead (585) (6) |
40. ohm20: Many folks will never be able to afford our drug (583) (11) |
41. Harpitdown: Not gonna lie...I don't hate (583) (3) |
42. ohm20: New' genetic Alzheimer's disease may impact 6.7 (582) (28) |
43. biloxiblues: I think everything hinges on what comes back from (580) (14) |
44. docj: I wonder if CYDY got the blessing, if not (579) (9) |
45. Boatbuilder: I’ve been an investor in this company for the (577) (14) |
46. Mrkev: Speaking of synergies as Figgs suggested, Just (576) (2) |
47. SamaGong: Good Luck , House-o-C! Dr. Jay himself said (573) (1) |
48. docj: Three weeks ago someone posted about a possible (568) (3) |
49. sean007: Not on my laptop...I saw it once...shortly after (566) (1) |
50. USS JOHNSTON: Question about the current company operations: (566) (2) |